![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT... Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. Show more
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual MedTech, Digital Health, Life...
Results demonstrate the importance of ultra-sensitive ctDNA detection in lung cancer Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at...
Full year revenue of ~$84.6 million represents a 15% year-over-year increase Cash balance of ~$185.0 million expected to provide runway to cash flow break-even Personalis, Inc. (Nasdaq: PSNL), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.43 | 8.48126232742 | 5.07 | 5.508 | 4.815 | 770700 | 5.18106337 | CS |
4 | -0.015 | -0.271985494107 | 5.515 | 6.2737 | 4.7 | 975021 | 5.39829855 | CS |
12 | 0.74 | 15.5462184874 | 4.76 | 7.19 | 3.28 | 1058841 | 5.10517747 | CS |
26 | 2.34 | 74.0506329114 | 3.16 | 7.2 | 2.81 | 1036600 | 5.15395909 | CS |
52 | 4.29 | 354.545454545 | 1.21 | 7.2 | 1.12 | 813910 | 4.20440919 | CS |
156 | -6.04 | -52.3396880416 | 11.54 | 12.96 | 0.8906 | 566759 | 3.79931899 | CS |
260 | -5.57 | -50.3161698284 | 11.07 | 53.46 | 0.8906 | 573371 | 12.05227845 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions